Evidence map›Paper›PMID 42319624›Full record

ReviewHeart failure reviews2026

Beyond the right ventricle: left heart involvement in pulmonary arterial hypertension.

María José Cabada-García, Jahir Rodríguez-Rivera, Jathniel Panneflek, Salma Andrade-Leal, Ana Lucía Martínez-Rodríguez, Enrique Paredes-Gutiérrez, Humberto De Leon-Gutierrez, Andres Gerardo Peña-Bladé, Raul Monjaras-Alvarado, Jesús Antonio Morón-Mosso and 7 more

Abstract readReview
In one paragraph

Review in Heart failure reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

María José Cabada-GarcíaTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Jahir Rodríguez-RiveraTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Jathniel PanneflekTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Salma Andrade-LealTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Ana Lucía Martínez-RodríguezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Enrique Paredes-GutiérrezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Humberto De Leon-GutierrezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Andres Gerardo Peña-BladéTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Raul Monjaras-AlvaradoTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Jesús Antonio Morón-MossoTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Alejandra TorresTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
Daniel AguirreTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico.
María José SerranoUniversidad del Valle de Mexico, Campus Queretaro, Queretaro, Mexico.
Carlos Jerjes Sanchez-RamirezCardiac Imaging Department, Hospital MAC La Viga, Ciudad de Mexico, Mexico.
Pedro Gutiérrez-FajardoHospital de Especialidades San Francisco de Asis, Cardiotest, Laboratorio de Ecocardiografia, Guadalajara, Jalisco, Mexico.
Alicia Ramirez-RiveraUnidad de Investigacion Clinica en Medicina SC, Head of Pulmonary Hypertension Clinic, Monterrey, Nuevo Leon, Mexico.
Carlos Jerjes-SanchezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza Garcia, Av. Morones Prieto 3000, Nuevo Leon, C.P., 64710, Mexico. carlosjerjes@tec.mx.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary arterial hypertension (PAH) is characterized by progressive remodeling of the pulmonary vasculature, leading to increased pulmonary vascular resistance and chronic right ventricular (RV) pressure overload. As RV dysfunction develops, ventricular interdependence alters the structural and functional relationship between the right and left ventricles. Although normal left-sided filling pressures define PAH, growing evidence indicates that left ventricular (LV) mechanics may be substantially affected. Leftward septal displacement, pericardial constraint, and reduced pulmonary venous return contribute to chronic underfilling of the left atrium and LV, impairing ventricular geometry and contractile dynamics despite preserved intrinsic myocardial function. However, secondary myocardial remodeling in advanced disease remains debated. These alterations may lead to subclinical or overt LV dysfunction and represent an underrecognized component of PAH pathobiology. Imaging markers such as LV global longitudinal strain, LV outflow tract velocity-time integral, and left atrial strain have emerged as potential indicators of left-sided involvement and may provide additional prognostic information. In this narrative review, we summarize current evidence on the pathobiological mechanisms linking RV dysfunction to left-sided cardiac alterations and discuss the role of ventricular interdependence in the coupling of the pulmonary circulation. Understanding this interaction may help redefine PAH as a progressive biventricular syndrome and may improve risk stratification and clinical assessment.

Indexed as

Hypertension, PulmonaryPulmonary Arterial HypertensionVentricular Dysfunction, LeftVentricular Dysfunction, RightVentricular RemodelingGlobal Longitudinal StrainHeart VentriclesHumansVentricular Function, RightCardiac imagingLeft atriumLeft ventriclePathobiologyPulmonary arterial hypertensionVentricular interdependence

Identifiers

PMID42319624
PMCPMC13282292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.